Abstract
Concomitant chemoradiotherapy represents an investigational approach to the treatment of locoregionally advanced non-small cell lung cancer. The theoretical rationale, and clinical experience are reviewed in brief. Clinical trials conducted at the University of Chicago are summarized.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Non-Small-Cell Lung / drug therapy
-
Carcinoma, Non-Small-Cell Lung / mortality
-
Carcinoma, Non-Small-Cell Lung / radiotherapy
-
Carcinoma, Non-Small-Cell Lung / therapy*
-
Chicago / epidemiology
-
Cisplatin / administration & dosage
-
Clinical Trials as Topic
-
Clinical Trials, Phase I as Topic
-
Clinical Trials, Phase II as Topic
-
Combined Modality Therapy
-
Fluorouracil / administration & dosage
-
Humans
-
Hydroxyurea / administration & dosage
-
Immunologic Factors / therapeutic use
-
Interferon-alpha / therapeutic use
-
Leucovorin / administration & dosage
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / mortality
-
Lung Neoplasms / radiotherapy
-
Lung Neoplasms / therapy*
-
Pilot Projects
-
Randomized Controlled Trials as Topic
-
Treatment Outcome
Substances
-
Immunologic Factors
-
Interferon-alpha
-
Cisplatin
-
Leucovorin
-
Fluorouracil
-
Hydroxyurea